Correlation Between Milestone Scientific and Nephros

Can any of the company-specific risk be diversified away by investing in both Milestone Scientific and Nephros at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Scientific and Nephros into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Milestone Scientific and Nephros, you can compare the effects of market volatilities on Milestone Scientific and Nephros and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Scientific with a short position of Nephros. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Scientific and Nephros.

Diversification Opportunities for Milestone Scientific and Nephros

0.33

Correlation Coefficient

Milestone Scientific  Nephros

Weak diversification

The 3 months correlation between Milestone and Nephros is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Scientific and Nephros in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nephros and Milestone Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Scientific are associated (or correlated) with Nephros. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nephros has no effect on the direction of Milestone Scientific i.e., Milestone Scientific and Nephros go up and down completely randomly.

Pair Corralation between Milestone Scientific and Nephros

Given the investment horizon of 90 days Milestone Scientific is expected to generate 2.14 times more return on investment than Nephros. However, Milestone Scientific is 2.14 times more volatile than Nephros. It trades about 0.02 of its potential returns per unit of risk. Nephros is currently generating about 0.02 per unit of risk. If you would invest  99.00  in Milestone Scientific on November 28, 2024 and sell it today you would lose (3.00) from holding Milestone Scientific or give up 3.03% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Milestone Scientific  vs.  Nephros

Milestone Scientific

Risk-Adjusted Performance

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Milestone Scientific are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Milestone Scientific is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Nephros

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Nephros are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Nephros is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Milestone Scientific and Nephros

The main advantage of trading using opposite Milestone Scientific and Nephros positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Scientific position performs unexpectedly, Nephros can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nephros will offset losses from the drop in Nephros' long position.

The idea behind Milestone Scientific and Nephros pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.